Overview Fundamentals API Earnings EOD API Sample Code Pricing

Kalvista Pharmaceuticals Inc (KALV NASDAQ) stock market data APIs

$15 0.03(0.2%) as of July 17, 2024
Price chart is built with Anychart

KalVista Pharmaceuticals, Inc., a clinical stage pharmaceutical company, engages in the discovery, development, and commercialization of drug therapies inhibitors for diseases with unmet needs. The company's product candidate is Sebetralstat, a small molecule plasma kallikrein inhibitor targeting the disease of hereditary angioedema (HAE). It develops Factor XIIa, an oral inhibitor for the treatment of HAE which is in preclinical trial. In addition, the company is developing an orally disintegrating tablet formulation, including KONFIDENT-KID for pediatric use with HAE; KONFIDENT-S for adolescent and adult patients with type I or type II HAE; and KONFIDENT for a potential oral therapy for HAE attacks. The company is headquartered in Cambridge, Massachusetts.

Kalvista Pharmaceuticals Inc Financial Data Overview

636 M
42 736 K
3 824 K
Our easy-to-use no-coding solutions help you get the data effortlessly:

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

General: {
Code: 'KALV',
Type: 'Common Stock',
Name: 'Kalvista Pharmaceuticals Inc',
Exchange: 'NASDAQ',
CurrencyCode: 'USD',
CurrencyName: 'US Dollar',
CurrencySymbol: '$',
CountryName: 'USA',
CountryISO: 'US',
OpenFigi: 'BBG0026ZG5B0',
CIK: '1348911',
EmployerIdNumber: '20-0915291',
FiscalYearEnd: 'April',
IPODate: '2015-04-09',
InternationalDomestic: 'Domestic',
Sector: 'Healthcare',
Industry: 'Biotechnology',
HomeCategory: 'Domestic',
IsDelisted: false,

Kalvista Pharmaceuticals Inc Fundamental Data is available in our Financial Data APIs

  • Net Revenue 3 824 K
  • EBITDA -139 628 992
  • Earnings Per Share -3.44
  • Income Statements
  • Balance Sheets
  • Cash flows
Get sample
of Fundamental API Data

Get Kalvista Pharmaceuticals Inc Earnings via APIs

  • Latest Release 2024-07-11
  • EPS/Forecast -0.73

Get Kalvista Pharmaceuticals Inc End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends
Do you have any questions?